ABSTRACT
Diffraction instruments using filtering by one or several analyser crystals exist since the 1980s and 1990s at synchrotron radiation sources, but, due to its low efficiency, this filtering is little used on laboratory sources. In order to overcome this limitation, the efficiency of a small diffraction filtering multi-analyzer block (MAD block) realized with a `single-crystal-comb' curved on a rigid support is demonstrated here. The geometry of this curved surface is logarithmic spiral and is optimized to allow multi-filtering over a relatively important diffraction angular range and to be also applicable over an X-ray spectral range. The efficiency of such a small rigid-compact MAD block consisting of this single-crystal-comb generating 20-50 Si(111) single-crystal blades, associated with a block of Soller collimators, is demonstrated. The angle between each crystal is 0.1°, so the measurement range of the comb is 2-5°. The geometry of this system has been optimized for operation with a synchrotron X-ray source over an energy range of 22â keV to 46â keV and could be used with laboratory X-ray sources (Agâ Kα1, 22.1â keV). This MAD block complements and exploits the qualities of the `photon-counting' detectors which have very low intrinsic noise. Their joint efficacy is supported by powder pattern measurements of a LaB6 reference sample and of several heterogeneous samples of cultural heritage materials, carried out at 22â keV on the D2AM beamline at the ESRF. Their signal-to-noise ratio is excellent (1000/1) and allows the detection thresholds of the measurements (from 3-1% to 0.1%) to detect minor phases in the studies of `real' heterogeneous materials to be drastically improved.
ABSTRACT
Vacuum quantum fluctuations near horizons are known to yield correlated emission by the Hawking effect. We use a driven-dissipative quantum fluid of microcavity polaritons as an analog model of a quantum field theory on a black-hole spacetime and numerically calculate correlated emission. We show that, in addition to the Hawking effect at the sonic horizon, quantum fluctuations may result in a sizable stationary excitation of a quasinormal mode of the field theory. Observable signatures of the excitation of the quasinormal mode are found in the spatial density fluctuations as well as in the spectrum of Hawking emission. This suggests an intrinsic fluctuation-driven mechanism leading to the quantum excitation of quasinormal modes on black hole spacetimes.
ABSTRACT
Characterizing elementary excitations in quantum fluids is essential to study their collective effects. We present an original angle-resolved coherent probe spectroscopy technique to study the dispersion of these excitation modes in a fluid of polaritons under resonant pumping. Thanks to the unprecedented spectral and spatial resolution, we observe directly the low-energy phononic behavior and detect the negative-energy modes, i.e., the ghost branch, of the dispersion relation. In addition, we reveal narrow spectral features precursory of dynamical instabilities due to the intrinsic out-of-equilibrium nature of the system. This technique provides the missing tool for the quantitative study of quantum hydrodynamics in polariton fluids.
ABSTRACT
The first measurement of lepton-jet momentum imbalance and azimuthal correlation in lepton-proton scattering at high momentum transfer is presented. These data, taken with the H1 detector at HERA, are corrected for detector effects using an unbinned machine learning algorithm (multifold), which considers eight observables simultaneously in this first application. The unfolded cross sections are compared with calculations performed within the context of collinear or transverse-momentum-dependent factorization in quantum chromodynamics as well as Monte Carlo event generators.
ABSTRACT
Analogue gravity enables the study of fields on curved space-times in the laboratory. There are numerous experimental platforms in which amplification at the event horizon or the ergoregion has been observed. Here, we demonstrate how optically generating a defect in a polariton microcavity enables the creation of one- and two-dimensional, transsonic fluid flows. We show that this highly tuneable method permits the creation of horizons. Furthermore, we present a rotating geometry akin to the water-wave bathtub vortex. These experiments usher in the possibility of observing stimulated as well as spontaneous amplification by the Hawking, Penrose and Zeld'ovich effects in fluids of light. This article is part of a discussion meeting issue 'The next generation of analogue gravity experiments'.
ABSTRACT
The goal of this paper is to express simply the number of photons impinging on a target in the framework of accelerator-based Compton X-ray sources. From the basic kinematics of Compton sources, analytic formulas for the angular and the spectral fluxes are established as functions of the energy spread or/and the angular divergence of the electron and the laser beams. Their detailed predictions are compared with Monte Carlo simulations. These analytic expressions allow one to compute in a simple and precise way the X-ray flux in a given angular acceptance and a given energy bandwidth, knowing the characteristics of the incoming beams.
ABSTRACT
Prostate cancer is the most common cancer and the third leading cause of cancer mortality in men. Each year, approximately 10% of prostate cancers are diagnosed metastatic at initial presentation. The standard treatment option for de-novo metastatic prostate cancer is androgen deprivation therapy with novel hormonal agent or with chemotherapy. Recently, PEACE-1 trial highlighted the benefit of triplet therapy resulting in the combination of androgen deprivation therapy combined with docetaxel and abiraterone. Radiotherapy can be proposed in a curative intent or to treat local symptomatic disease. Nowadays, radiotherapy of the primary disease is only recommended for de novo low-burden/low-volume metastatic prostate cancer, as defined in the CHAARTED criteria. However, studies on stereotactic radiotherapy on oligometastases have shown that this therapeutic approach is feasible and well tolerated. Prospective research currently focuses on the benefit of intensification by combining treatment of the metastatic sites and the primary all together. The contribution of metabolic imaging to better define the target volumes and specify the oligometastatic character allows a better selection of patients. This article aims to define indications of radiotherapy and perspectives of this therapeutic option for de-novo metastatic prostate cancer.
Subject(s)
Prostatic Neoplasms , Humans , Male , Androgen Antagonists/therapeutic use , Docetaxel , Prospective Studies , Prostatic Neoplasms/pathology , Clinical Trials as TopicABSTRACT
In Saccharomyces cerevisiae, the product of the CDC25 gene controls the RAS-mediated production of adenosine 3',5'-monophosphate (cAMP). In vivo the carboxyl-terminal third of the CDC25 gene product is sufficient for the activation of adenylate cyclase. The 3'-terminal part of SCD25, a gene of S. cerevisiae structurally related to CDC25, can suppress the requirement for CDC25. Partially purified preparations of the carboxy-terminal domain of the SCD25 gene product enhanced the exchange rate of guanosine diphosphate (GDP) to guanosine triphosphate (GTP) of pure RAS2 protein by stimulating the release of GDP. This protein fragment had a similar effect on the human c-H-ras-encoded p21 protein. Thus, the SCD25 carboxyl-terminal domain can enhance the regeneration of the active form of RAS proteins.
Subject(s)
Cell Cycle Proteins , Fungal Proteins/metabolism , Fungal Proteins/pharmacology , Guanine Nucleotides/metabolism , Guanosine Diphosphate/metabolism , Guanosine Triphosphate/metabolism , Peptide Fragments/pharmacology , Saccharomyces cerevisiae Proteins , ras Proteins , ras-GRF1 , Escherichia coli/genetics , Fungal Proteins/genetics , Genes, Fungal , Humans , Kinetics , Plasmids , Proto-Oncogene Proteins/metabolism , Proto-Oncogene Proteins p21(ras) , Recombinant Fusion Proteins , Saccharomyces cerevisiae/genetics , TransfectionABSTRACT
Randomized trials demonstrated similar overall survival between mastectomy and breast-conservative surgery followed by adjuvant radiation therapy. Breast-conservative surgery, with adjuvant radiation therapy, with or without neoadjuvant systemic therapy has become the standard of care for women with early or locally advanced breast cancer. Nevertheless, certain cardiac, lung or cutaneous toxicities may alter the long-term body image and the quality of life of a limited number of patients who consider having had "overtreatment" or treatment outside the best knowledge of science. In case of low-risk breast cancer, several trials have evaluated the carcinologic outcome in absence of radiation therapy after breast-conservative surgery. Local recurrences increased in case of breast-conservative surgery alone but without impact on overall survival. Multiple debates have emerged in order to select the most appropriate evaluation criteria. Finally, a large consensus has considered that reducing local recurrences is important but with modern technologies and after identifying patients of individual radiosensitivity. Indeed, in case of a low absolute risk of local recurrence, radiation therapy techniques have been developed to allow a focal treatment especially for patients with high risk of developing late effects. This kind of compromise takes into account the reduction risk of local recurrences but also the probability of developing radiation-induced cutaneous sequelae. In the same way, for patients considered at high risk of recurrence, the huge volumes need specific techniques to better cover the targets while protecting the surrounding critic organs such as heart and lung. Intensity-modulated radiation therapy and the local high boost may help to decrease local recurrences of these more extended and aggressive diseases while considering the individual radiosensitivity that paves the way of long-term sequelae. In this article, we detail a personalized approach of breast radiation therapy considering the absolute risk of local recurrences and the probability of radiation-induced toxicity appearance.
Subject(s)
Breast Neoplasms/radiotherapy , Precision Medicine/methods , Radiation Injuries/etiology , Adult , Age Factors , Aged , Breast Neoplasms/pathology , Breast Neoplasms/prevention & control , Dose Fractionation, Radiation , Female , Humans , Middle Aged , Neoplasm Recurrence, Local/prevention & control , Organs at Risk/radiation effects , Radiation Tolerance , Risk Assessment , Tumor BurdenABSTRACT
We propose in this short review to report the impact of stereotactic body radiation therapy (SBRT) in oligometastatic or oligoprogressive cancer patients in terms of metastatic progression-free and global survival, and to identify the place of SBRT in patient's pathway.
Subject(s)
Breast Neoplasms/radiotherapy , Carcinoma, Non-Small-Cell Lung/radiotherapy , Lung Neoplasms/radiotherapy , Prostatic Neoplasms/radiotherapy , Radiosurgery/methods , Breast Neoplasms/pathology , Cancer Survivors , Carcinoma, Non-Small-Cell Lung/pathology , Carcinoma, Non-Small-Cell Lung/secondary , Disease Progression , Female , Humans , Lung Neoplasms/pathology , Male , Neoplasm Metastasis , Prognosis , Prostatic Neoplasms/pathology , Randomized Controlled Trials as TopicABSTRACT
The impact of curative radiotherapy depends mainly on the total dose delivered homogenously in the target volume. Tumor sensitivity to radiotherapy may be particularly inconstant depending on location, histology, somatic genetic parameters and the capacity of the immune system to infiltrate the tumor. In addition, the dose delivered to the surrounding healthy tissues may reduce the therapeutic ratio of many radiation treatments. In a same population treated in one center with the same technique, it appears that individual radiosensitivity clearly exists, namely in terms of late side effects that are in principle non-reversible. This review details the different radiobiological approaches that have been developed to better predict the tumor response but also the radiation-induced late effects.
Subject(s)
Neoplasms/radiotherapy , Organs at Risk/radiation effects , Radiation Tolerance , Biomarkers, Tumor , Blood Cells/radiation effects , DNA Repair/genetics , Humans , Neoplasms/genetics , Organ Specificity , Prognosis , Proteomics , Radiation Injuries/etiology , Radiotherapy Dosage , Sensitivity and Specificity , Treatment OutcomeABSTRACT
Bilateral intradentate injections of 3.0microg of colchicine induced a substantial loss of granule cells and damage to the overlying pyramidal cell layer in region CA1 in adult male Long-Evans rats. All rats with such lesions showed a significant associative learning deficit in an olfactory discrimination task, while being unimpaired in the procedural component of this task. Injection of a partial selective 5-HT(4) agonist (SL65.0155; 0.01mg/kg, i.p., vs. saline) before the third of six training sessions enabled complete recovery of associative learning performance in the lesioned rats. Activation of 5-HT(4) receptors by a selective agonist such as SL65.0155 might therefore provide an opportunity to reduce learning and memory deficits associated with temporal lobe damage, and could be useful for the symptomatic treatment of memory dysfunctions related to pathological aging such as Alzheimer's disease.
Subject(s)
Dioxanes/pharmacology , Memory Disorders/drug therapy , Memory Disorders/physiopathology , Oxadiazoles/pharmacology , Receptors, Serotonin, 5-HT4/physiology , Serotonin 5-HT4 Receptor Agonists , Smell/physiology , Animals , Association Learning/drug effects , Association Learning/physiology , Behavior, Animal/drug effects , Behavior, Animal/physiology , Colchicine/toxicity , Denervation , Dentate Gyrus/pathology , Dentate Gyrus/physiology , Discrimination Learning/drug effects , Discrimination Learning/physiology , Male , Pyramidal Cells/pathology , Pyramidal Cells/physiology , Rats , Rats, Long-Evans , Reversal Learning/drug effects , Reversal Learning/physiologyABSTRACT
BACKGROUND: An active haemovigilance programme was implemented to survey adverse events (AE) associated with transfusion of platelets photochemically treated with amotosalen and ultraviolet A (PCT-PLT). The results of 5106 transfusions have already been reported. Here we report the results of an additional 7437 PCT-PLT transfusions. METHODS: The focus of this ongoing haemovigilance programme is to document all AEs associated with PCT-PLT transfusion. Data collected for AEs include: time of event after starting transfusion, clinical descriptions, vital signs, results from radiographs and bacterial cultures, event severity (Grade 0-4) and causal relationship to PCT-PLT transfusion. RESULTS: One thousand four hundred patients (mean 60 years, range 1-96) received PCT-PLT transfusions. The majority of the patients (53.4%) had haematology-oncology diseases and required conventional chemotherapy (44.8%) or stem cell transplantation (8.6%). Sixty-eight PCT-PLT transfusions were associated with AE. Acute transfusion reactions (ATR), classified as an AE possibly related, probably related, or related to PCT-PLT transfusions were infrequent (n = 55, 55/7437 = 0.7%) and most were of Grade 1 severity. Thirty-nine patients (39/1400 = 2.8%) experienced one or more ATRs. The most frequently reported signs/symptoms were chills, fever, urticaria, dyspnoea, nausea and vomiting. Five AEs were considered severe (> or = Grade 2); however, no causal relationship to PCT-PLT transfusion was found. Repeated exposure to PCT-PLT did not increase the likelihood of an ATR. No cases of transfusion-related acute lung injury and no deaths due to PCT-PLT transfusions were reported. CONCLUSIONS: Routine transfusion of PCT-PLT is well-tolerated in a wide range of patients. ATRs related to PCT-PLT transfusion were infrequent and most were of mild severity.
Subject(s)
Blood Platelets , Blood Preservation/methods , Platelet Transfusion/adverse effects , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Female , Furocoumarins/therapeutic use , Humans , Infant , Male , Middle Aged , Photosensitizing Agents/therapeutic use , Prospective Studies , Ultraviolet RaysABSTRACT
The management of the documentation is one of the key points regarding the efficacy and the performance of the quality management of health centres. It offers to all professionals the possibility to be informed on the procedures in use, leading to a pool of documents for improvement of organisations and for securing the critical steps of the patient management. In this paper, we will describe the optimal organisation of the documentation according to Haute autorité de santé (HAS) and ISO recommendations, then we will discuss in concrete terms the potential methods usable for the production of a tool well adapted to our routine practice, in order to achieve the objectives for security.
Subject(s)
Documentation/standards , Radiotherapy/standards , Language , Quality Assurance, Health Care , SafetyABSTRACT
In the yeast Saccharomyces cerevisiae, the activation of adenylate cyclase requires the products of the RAS genes and of CDC25. We isolated several dominant extragenic suppressors of the yeast cdc25 mutation. They did not suppress a thermosensitive allele of the adenylate cyclase gene (CDC35). One of these suppressors was a mutated RAS2 gene in which the transition C/G----T/A at position 455 resulted in replacement of threonine 152 by isoleucine in the protein. The same mutation in a v-Ha-ras gene reduces the affinity of p21 for guanine nucleotides (L.A. Feig, B. Pan, T.M. Roberts, and G.M. Cooper, Proc. Natl. Acad. Sci. USA 83:4607-4611, 1986). These results support a model in which the CDC25 gene product is the GDP-GTP exchange factor regulating the activity of the RAS gene product.
Subject(s)
Gene Expression Regulation , Genes, ras , Mutation , Saccharomyces cerevisiae/growth & development , Adenylyl Cyclases/genetics , Adenylyl Cyclases/metabolism , Saccharomyces cerevisiae/genetics , Suppression, GeneticABSTRACT
In the yeast Saccharomyces cerevisiae, the CDC25 gene product activates adenylate cyclase through RAS1 and RAS2 gene products. We have recently described the cloning of a DNA fragment which suppresses the cdc25 mutation but not ras1, ras2, or cdc35 mutations. This fragment contains a 5'-truncated open reading frame which shares 47% identity with the C-terminal part of the CDC25 gene. We named the entire gene SDC25. In this paper, we report the cloning, sequencing, and characterization of the complete SDC25 gene. The SDC25 gene is located on the chromosome XII close to the centromere. It is transcribed into a 4-kb-long mRNA that contains an open reading frame of 1,251 codons. Homology with the CDC25 gene extends in the N-terminal part, although the degree of similarity is lower than in the C-terminal part. In contrast with the C-terminal part, the complete SDC25 gene was found not to suppress the CDC25 gene defect. A deletion in the N-terminal part restored the suppressing activity, a result which suggests the existence of a regulatory domain. The SDC25 gene was found to be dispensable for cell growth under usual conditions. No noticeable phenotype was found in the deleted strain.
Subject(s)
Cell Cycle Proteins , Fungal Proteins/genetics , GTP-Binding Proteins/genetics , Genes, Fungal , Saccharomyces cerevisiae Proteins , Saccharomyces cerevisiae/genetics , ras Proteins , ras-GRF1 , Base Sequence , Blotting, Northern , Cloning, Molecular , DNA Mutational Analysis , DNA, Fungal/genetics , Gene Expression Regulation, Fungal , Genes, Suppressor , Molecular Sequence Data , Phenotype , RNA, Fungal/genetics , RNA, Messenger/genetics , Restriction Mapping , rap GTP-Binding ProteinsABSTRACT
We have performed a differential screen of a Xenopus egg cDNA library and selected two clones (Cl1 and Cl2) corresponding to mRNA which are specifically adenylated and recruited into polysomes after fertilization. Sequence analysis of Cl1 reveals that the corresponding protein is 67.5% identical (83% similar) to the product of the Saccharomyces cerevisiae SUP45 (also called SUP1 or SAL4) gene. This gene, when mutated, is an omnipotent suppressor of nonsense codons. When expressed in a sup45 mutant, the Xenopus Cl1 cDNA was able to suppress sup45-related phenotypes, showing that the structural homology reflects a functional homology. Our discovery of a structural and functional homolog in Xenopus cells implies that the function of SUP45 is not restricted to lower eukaryotes and that the SUP45 protein may perform a crucial cellular function in higher eukaryotes.
Subject(s)
DNA/genetics , Egg Proteins/genetics , Fungal Proteins/genetics , Gene Expression Regulation , Peptide Termination Factors , Protein Biosynthesis , RNA, Messenger/metabolism , Saccharomyces cerevisiae Proteins , Saccharomyces cerevisiae/genetics , Xenopus laevis/genetics , Amino Acid Sequence , Animals , Base Sequence , Brain/physiology , DNA/isolation & purification , Embryo, Nonmammalian/physiology , Female , Fertilization , Gene Library , Genes, Fungal , Heart/physiology , Liver/physiology , Male , Molecular Sequence Data , Oocytes/physiology , RNA, Messenger/genetics , Restriction Mapping , Sequence Homology, Amino Acid , Suppression, Genetic , Testis/physiology , Xenopus laevis/embryologyABSTRACT
A multisubunit complex in the mitochondrial outer membrane is responsible for targeting and membrane translocation of nuclear-encoded preproteins. This receptor complex contains two import receptors, a general insertion pore and the protein Mom22. It was unknown if Mom22 directly interacts with preproteins, and two views existed about the possible functions of Mom22: a central role in transfer of preproteins from both receptors to the general insertion pore or a more limited function dependent on the presence of the receptor Mom19. For this report, we identified and cloned Saccharomyces cerevisiae MOM22 and investigated whether it plays a direct role in targeting of preproteins. A preprotein accumulated at the mitochondrial outer membrane was cross-linked to Mom22. The cross-linking depended on the import stage of the preprotein. Overexpression of Mom22 suppressed the respiratory defect of yeast cells lacking Mom19 and increased preprotein import into mom19 delta mitochondria, demonstrating that Mom22 can function independently of Mom19. Overexpression of Mom22 even suppressed the lethal phenotype of a double deletion of the two import receptors known so far (mom19 delta mom72 delta). Deletion of the MOM22 gene was lethal for yeast cells, identifying Mom22 as one of the few mitochondrial membrane proteins essential for fermentative growth. These results suggest that Mom22 plays an essential role in the mitochondrial receptor complex. It directly interacts with preproteins in transit and can perform receptor-like activities.
Subject(s)
Membrane Proteins/genetics , Membrane Transport Proteins , Mitochondria/metabolism , Receptors, Cell Surface , Saccharomyces cerevisiae Proteins , Amino Acid Sequence , Base Sequence , Cell Survival , Cloning, Molecular , Membrane Proteins/metabolism , Mitochondrial Membrane Transport Proteins , Molecular Sequence Data , Saccharomyces cerevisiae/cytology , Saccharomyces cerevisiae/metabolismABSTRACT
The SDC25 gene of Saccharomyces cerevisiae is homologous to CDC25. Its 3' domain encodes a guanine nucleotide exchange factor (GEF) for Ras. Nevertheless, the GEF encoded by CDC24 is determinant for the Ras/cAMP pathway activation in growth. We demonstrate that the SDC25 gene product is a functional GEF for Ras: the complete SDC25 gene functionally replaces CDC25 when overexpressed or when transcribed under CDC25 transcriptional control at the CDC25 locus. Chimeric proteins between Sdc25p and Cdc25p are also functional GEFs for Ras. We also show that the two genes are differentially regulated: SDC25 is not transcribed at a detectable level in growth conditions when glucose is the carbon source. It is transcribed at the end of growth when nutrients are depleted and in cells grown on nonfermentable carbon sources. In contrast, CDC25 accumulation is slightly reduced when glucose is replaced by a nonfermentable carbon source.